Exploring the Potential Effect of GLP1R Agonism on Common Aging-Related Diseases via Glucose Reduction: A Mendelian Randomization Study
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025
DOI: 10.1093/gerona/glaf007 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Wei Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Aging, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Glucagon-like peptide-1 receptor agonists (GLP1RAs) are widely used in managing type 2 diabetes mellitus and weight control. Their potential in treating aging-related diseases has been gaining attention in recent years. However, the long-term effects of GLP1RAs on these diseases have yet to be fully revealed.
Methods
Using a genetic variant in the GLP1R gene to model the long-term effects of GLP1RAs, this Mendelian randomization (MR) study systematically explored potential causal associations between GLP1R agonism and 12 aging-related diseases and indicators. Genetic summary data sets used in this study were obtained from previous genome-wide association studies.
Results
The primary MR analysis results suggested that GLP1R agonism was potentially positively causally associated with appendicular lean mass (Beta = 0.246, 95% confidence interval [CI] = 0.096–0.396), whole-body fat-free mass (Beta = 0.202, 95% CI = 0.048–0.355), and lung function (forced vital capacity [FVC]; Beta = 0.179, 95% CI = 0.152–0.205; p < .05). Additionally, a potential negative causal association was observed with myocardial infarction (odds ratio = 0.430, 95% CI = 0.249–0.745; p < .05).
Conclusions
The present MR study provides exploratory evidence suggesting potential causal associations between GLP1R agonism and appendicular lean mass, whole-body fat-free mass, lung function (FVC), and myocardial infarction. Given the exploratory nature of these findings and the limitations of the MR methodology, further research is needed to validate these results and investigate the underlying biological mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Department of Clinical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, W., Ding, K., Yang, M., Hu, Z., & Yue, R. (2025). Exploring the Potential Effect of GLP1R Agonism on Common Aging-Related Diseases via Glucose Reduction: A Mendelian Randomization Study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glaf007
Vancouver
Jiang W, Ding K, Yang M, Hu Z, Yue R. Exploring the Potential Effect of GLP1R Agonism on Common Aging-Related Diseases via Glucose Reduction: A Mendelian Randomization Study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glaf007
BibTeX
@article{Jiang2025,
author = {Jiang, Wei and Ding, Kaixi and Yang, Maoyi and Hu, Zhipeng and Yue, Rensong},
title = {Exploring the Potential Effect of GLP1R Agonism on Common Aging-Related Diseases via Glucose Reduction: A Mendelian Randomization Study},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2025},
doi = {10.1093/gerona/glaf007}
}
EUVIMED